AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca right-of-use (ROU) lease assets — net carrying value ($M) ($M)
Form 20-F Note 9 — Leases (Right-of-Use Assets)
Latest, Q2 2026
2,685
Period ended Jun 30, 2026
Change on a year earlier
+68.7%
1,592 in Q2 2025
History
16 quarters
Since Q4 2018
Sources
15
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Right-of-use (ROU) lease assets — net carrying value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 2,685 | +68.7% | Form 6-K (filed 2026-07-27) ↗ |
| Q4 2025 | Dec 31, 2025 | 1,741 | +24.8% | Form 20-F (filed 2026-02-24) ↗ |
| Q2 2025 | Jun 30, 2025 | 1,592 | +32.3% | Form 6-K (filed 2025-07-29) ↗ |
| Q4 2024 | Dec 31, 2024 | 1,395 | +26.8% | Form 20-F (filed 2025-02-18) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,203 | +26.8% | Form 6-K (filed 2024-07-25) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,100 | +16.8% | Form 20-F (filed 2024-02-20) ↗ |
| Q2 2023 | Jun 30, 2023 | 949 | +4.9% | Form 6-K (filed 2023-07-28) ↗ |
| Q4 2022 | Dec 31, 2022 | 942 | -4.7% | Form 20-F (filed 2023-02-21) ↗ |
| Q2 2022 | Jun 30, 2022 | 905 | +34.3% | Form 6-K (filed 2022-07-29) ↗ |
| Q4 2021 | Dec 31, 2021 | 988 | +48.3% | Form 20-F (filed 2022-02-22) ↗ |
| Q2 2021 | Jun 30, 2021 | 674 | +6.3% | Form 6-K (filed 2021-07-30) ↗ |
| Q4 2020 | Dec 31, 2020 | 666 | +2.9% | Form 20-F (filed 2021-02-16) ↗ |
| Q2 2020 | Jun 30, 2020 | 634 | -9.7% | Form 6-K/A (filed 2020-07-31) ↗ |
| Q4 2019 | Dec 31, 2019 | 647 | -10.4% | Form 20-F (filed 2020-03-03) ↗ |
| Q2 2019 | Jun 30, 2019 | 702 | – | Form 6-K (filed 2019-07-25) ↗ |
| Q4 2018 | Dec 31, 2018 | 722 | – | Form 20-F (filed 2021-02-16) ↗ |
Breakdown
What makes up right-of-use (rou) lease assets — net carrying value ($m)
Cite this data
StockData. (2026). AstraZeneca Right-of-use (ROU) lease assets — net carrying value ($M) ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rou_net_total
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.